BPNT2
protein-coding3'(2'), 5'-bisphosphate nucleotidase 2
Gene summary
This gene encodes a member of the inositol monophosphatase family. The encoded protein is localized to the Golgi apparatus and catalyzes the hydrolysis of phosphoadenosine phosphate (PAP) to adenosine monophosphate (AMP). Mutations in this gene are a cause of GRAPP type chondrodysplasia with joint dislocations, and a pseudogene of this gene is located on the long arm of chromosome 1. [provided by RefSeq, Dec 2011]
- IMPAD1
MANE transcript
Inheritance
ClinVar variants
Top phenotype
gnomAD constraint
Max pathogenic AF
Genomic locus
External References & Databases
Transcript & Mutation Effects
hg38 • Region Span ~35.9 kbGenCC Phenotypes & Disease Associations
Curated gene-disease validity assertions and inheritance patterns
Inheritance Pattern: AR
Disease ID:MONDO:0013561
Submitter: ClinGen
BPNT2 was first reported in relation to autosomal recessive Chondrodysplasia with joint dislocations GPAPP type (MONDO:0013561) in 2011 (Vissers LE et al., 2011; PMID:21549340). GPAPP deficiency is a genetic, primary bone dysplasia characterized by prenatal onset of disproportionate short stature, shortening of the limbs, congenital joint dislocations, micrognathia, posterior cleft palate, brachydactyly, short metacarpals and irregular size of the metacarpal epiphyses, supernumerary carpal ossification centers and dysmorphic facial features. In addition, hearing impairment and mild psychomotor delay have also been reported. The disease can be caused by homozygous mutation in the BPNT2 gene (614078) on chromosome 8q12.1. This gene encodes a member of the inositol monophosphatase family. The encoded protein is localized to the Golgi apparatus and catalyzes the hydrolysis of phosphoadebbnosine phosphate (PAP) to adenosine monophosphate (AMP). Mutations in this gene are a cause of GRAPP type chondrodysplasia with joint dislocations, and a pseudogene of this gene is on the long arm of chromosome 1 and has 3 transcripts. More than 300 unique variants (e.g., synonymous, missense, in-frame indel, nonsense, frameshift) have been reported in humans by ClinVar. Evidence supporting this gene-disease relationship includes case-level data and experimental data. 4 variants (2 nonsense, and 2 missense) that have been reported in approximately 4 probands in 2 publications (Venkatapuram VS et al., 2022; PMID: 34989141; Vissers LE et al., 2011; PMID:21549340). There is also a non-scorable publication that describes similar phenotypes of gPAPP deficiency but was not included in this curation (Nizon M et al., 2012; PMID:22887726). This gene-disease relationship is also supported by an animal models study (Frederick JP et al., 2008; PMID:18695242). In summary, there is moderate evidence to support the relationship between BPNT2 and Chondrodysplasia with joint dislocations GPAPP type. This has been repeatedly demonstrated in both the research and clinical diagnostic settings. This classification was approved by the ClinGen Congenital Disorders of Glycosylation GCEP on the meeting date XXX X, 2024 (SOP Version 10).
Inheritance Pattern: AR
Disease ID:MONDO:0013561
Submitter: PanelApp Australia
Inheritance Pattern: AR
Disease ID:MONDO:0013561
Submitter: Ambry Genetics
Inheritance Pattern: AR
Disease ID:MONDO:0013561
Submitter: Labcorp Genetics (formerly Invitae)
Inheritance Pattern: AR
Disease ID:MONDO:0013561
Submitter: Orphanet
Inheritance Pattern: AR
Disease ID:MONDO:0013561
Submitter: G2P
Clinical Genomic Database (CGD)
Manifestation: Craniofacial; Musculoskeletal
Intervention: General
Rationale: Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing
ClinVar Associated Diseases & Phenotypes
Reported disease conditions connected to BPNT2 variants in ClinVar
ClinVar Variants & Pathogenicity by Type
Statistics based on transcript NM_017813.5. Only rare variants are included.
We include only reliable ClinVar variants with their consequences to MANE Select, MANE Plus Clinical transcripts, or transcripts with TSL equal to 1. Click a count to filter the variants table below.
Slight differences between displayed counts and ClinVar may occur due to a different transcript/consequence chosen by our variant effect predictor, or because we classify Benign/Likely benign as Likely benign and Pathogenic/Likely pathogenic as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 5 | 46 | 1 | 52 | ||
| missense | 2 | 1 | 83 | 2 | 1 | 89 |
| nonsense | 2 | 2 | ||||
| start loss | 0 | |||||
| frameshift | 4 | 3 | 7 | |||
| splice donor/acceptor (+/-2bp) | 3 | 3 | ||||
| Total | 8 | 4 | 91 | 48 | 2 | 153 |
Highest pathogenic variant AF is 0.000013631593
Transcript Catalog
Annotated transcript isoforms across RefSeq and Ensembl databases
| Transcript ID | Source | Protein ID | Coding Exons | MANE Status |
|---|---|---|---|---|
| RefSeq | NP_060283.3 | 5 | MANE Select | |
| Ensembl | ENSP00000262644.4 | 5 | MANE Select | |
| Ensembl | ENSP00000430185.1 | 3 | Standard | |
| Ensembl | ENSP00000428617.1 | 3 | Standard |
Gene Ontology (GO) Annotations & Pathways
Biological processes, molecular functions, cellular components and pathways
Pathways ConsensusPathDB
- Inositol phosphate metabolism - Homo sapiens (human)
- Phosphatidylinositol signaling system - Homo sapiens (human)
- Sulfur metabolism - Homo sapiens (human)
- superpathway of D-<i>myo</i>-inositol (1,4,5)-trisphosphate metabolism
- Phase II - Conjugation of compounds
Biological Process
- skeletal system development
- endochondral ossification
- chondrocyte development
- inositol biosynthetic process
- post-embryonic development
Molecular Function
- 3'-nucleotidase activity
- 3'(2'),5'-bisphosphate nucleotidase activity
- inositol monophosphate 1-phosphatase activity
- metal ion binding
- inositol monophosphate 3-phosphatase activity
Cellular Component
- nucleus
- Golgi apparatus
- Golgi lumen
- cytosol
- membrane
gnomAD Constraint
Source:
- Gene type
- protein_coding
- Transcript type
- protein_coding
- Transcript
- ENST00000262644
- Coding exons
- 5
- Length
- 35912
- Individuals with no LoFs
- 125733
- Homozygous LoFs
- 0
- Heterozygous LoFs
- 15
- Defined
- 125748
- p
- 0.0000596
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible | |
|---|---|---|---|---|---|---|
| Missense | 0.830 | 159 | 191 | 0.831 | 0.00000935 | 2312 |
| Missense (PolyPhen) | 55 | 73.524 | 0.74806 | 853 | ||
| Synonymous | -1.79 | 97 | 77.0 | 1.26 | 0.00000399 | 747 |
| Loss of Function | 1.97 | 5 | 12.5 | 0.399 | 5.95e-7 | 156 |
Population LoF Frequency
| Population | CAF | p-value | Status |
|---|---|---|---|
| African | 0.000062 | 0.000062 | rare |
| Latino/Admixed American | 0.000029 | 0.000029 | rare |
| Ashkenazi Jewish | 0 | 0.0 | absent |
| East Asian | 0.000057 | 0.000054 | rare |
| Finnish | 0 | 0.0 | absent |
| European (Non-Finnish) | 0.000098 | 0.000097 | rare |
| South Asian | 0.000033 | 0.000033 | rare |
| Other | 0 | 0.0 | absent |
dbNSFP Gene Annotations
Source:
- Function
- FUNCTION: May play a role in the formation of skeletal elements derived through endochondral ossification, possibly by clearing adenosine 3',5'-bisphosphate produced by Golgi sulfotransferases during glycosaminoglycan sulfation. {ECO:0000250}.;
- Disease
- DISEASE: Chondrodysplasia with joint dislocations, GPAPP type (CDP-GPAPP) [MIM:614078]: A condition consisting of congenital joint dislocations, chondrodysplasia with short stature, micrognathia and cleft palate, and a distinctive face. {ECO:0000269|PubMed:21549340}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
Recessive Scores
- pRec
- 0.106
Intolerance Scores
- LoFtool
- 0.242
- RVIS EVS
- -0.32
- RVIS percentile EVS
- 31.69
Essentials
- Essential (CRISPR)
- N
- Essential (CRISPR2)
- N
- Essential (gene trap)
- N
- Indispensability pred.
- N
- Indispensability score
- 0.307
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Medium | Medium |
| Primary Immunodeficiency | Medium | Medium | Medium |
| Cancer | Medium | Medium | Medium |